Ruxolitinib prior to allogenic stem cell transplant in patients with myelofibrosis

Trial Profile

Ruxolitinib prior to allogenic stem cell transplant in patients with myelofibrosis

Recruiting
Phase of Trial: Phase III

Latest Information Update: 14 Aug 2014

At a glance

  • Drugs Ruxolitinib (Primary)
  • Indications Myelofibrosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Aug 2014 New trial record
    • 07 Dec 2013 Primary endpoint has been met. (Improvement in symptoms)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top